Man Group’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-430,984
| Closed | -$10.3M | – | 2188 |
|
|
2021
Q1 | $10.3M | Buy |
+430,984
| New | +$8.01M | 0.05% | 416 |
|
|
2020
Q4 | – | Sell |
-40,439
| Closed | -$574K | – | 1994 |
|
|
2020
Q3 | $574K | Sell |
40,439
-11,200
| -22% | -$171K | ﹤0.01% | 1522 |
|
|
2020
Q2 | $760K | Buy |
+51,639
| New | +$525K | ﹤0.01% | 1350 |
|
|
2020
Q1 | – | Sell |
-70,054
| Closed | -$337K | – | 1996 |
|
|
2019
Q4 | $337K | Sell |
70,054
-25,200
| -26% | -$139K | ﹤0.01% | 1653 |
|
|
2019
Q3 | $577K | Sell |
95,254
-50,846
| -35% | -$317K | ﹤0.01% | 1546 |
|
|
2019
Q2 | $948K | Buy |
146,100
+2,400
| +2% | +$16.9K | ﹤0.01% | 1547 |
|
|
2019
Q1 | $1.02M | Buy |
+143,700
| New | +$946K | ﹤0.01% | 1572 |
|
|
2018
Q3 | – | Sell |
-15,000
| Closed | -$96K | – | 2281 |
|
|
2018
Q2 | $96K | Buy |
+15,000
| New | +$99.1K | ﹤0.01% | 2072 |
|
Man Group's GNMK Position: Q2 2021 in Review
Man Group sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 430,984 shares — an estimated $10.3M sold.
Man Group first reported a position in GNMK in Q2 2018 and held it in 8 quarters. The position peaked at $10.3M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Man Group reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Man Group sold 430,984 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $10.3M.
- Man Group first reported a position in GenMark Diagnostics, Inc in Q2 2018 and held it in 8 quarters.
- Man Group's GenMark Diagnostics, Inc position peaked at $10.3M in Q1 2021.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Man Group's 13F filing for Q2 2021, filed 16 Aug 2021.